Literature DB >> 12454336

Treatment of coronary bifurcation lesions by stent implantation only in parent vessel and angioplasty in sidebranch: immediate and long-term outcome.

Pavel Cervinka1, Joseph Stasek, Miloslav Pleskot, Jaroslav Malý.   

Abstract

The aim of this study was to evaluate the immediate and long-term outcome of intracoronary stent implantation for the treatment of bifurcation lesions. We treated 30 patients with bifurcation stenosis with the Bx Velocity stent implanted only in the parent vessel and with balloon angioplasty of the sidebranch. Angiographic success was 86.7% (n = 26 patients) in both branches and 100% in the main branch. Clinical success was achieved in 29 patients (96.7%). One patient (3.3%) suffered from a small non-Q wave myocardial infarction. All 30 patients underwent control coronary angiography at 6 months unless performed earlier due to symptoms. After the 6-month follow-up, a total of 27 patients (90%) were asymptomatic; angiographic restenosis (> 50%) was found in four cases (13.3%). There was no sidebranch restenosis. During the follow-up, one patient (3.3%) had unstable angina and angiography revealed severe diffuse restenosis within the whole stent; this patient was referred for coronary artery bypass surgery. Two patients had mild angina (Canadian Cardiovascular Society Class II) and 1 patient had silent ischemia during exercise stress test. These patients underwent repeat coronary angioplasty. The rate of major adverse cardiac events was 16.6% and target vessel revascularization rate was 13.3%. We concluded that stent implantation only in the parent vessel with angioplasty of the sidebranch in bifurcation lesions is safe and has a high clinical success rate and low rate of target lesion revascularization.

Entities:  

Mesh:

Year:  2002        PMID: 12454336

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  3 in total

1.  Intermediate term outcomes with bifurcation coronary stenting using the paclitaxel drug-eluting stent: a single centre experience.

Authors:  Nicolas W Shammas; Eric J Dippel; Gail A Shammas; Leslie Farland; Stephanie Brosius; Michael Jerin; Amber Avila; Lauren Gehbauer; Matthew Winter; Penny Stoakes; Jeannette Byrd; Peter Sharis; Jon Robken
Journal:  Int J Angiol       Date:  2008

2.  Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention.

Authors:  Josef Veselka; Sárka Procházková; Radka Duchonová; Ingrid Homolová; David Tesar; Kevin A Bybee
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

Review 3.  Drug eluting stents: focus on Cypher sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions.

Authors:  Alaide Chieffo; Tiziana Claudia Aranzulla; Antonio Colombo
Journal:  Vasc Health Risk Manag       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.